Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REASON: Acetyl-L-Carnitine for Sagopilone-induced Neuropathy
NCT00751205Phase 2Completed
- Sponsor
- Bayer
- Start
- Aug 2008
- Primary completion
- Feb 2010
- Modality
- Small Molecules
- Countries
- 6
01
Overview
Phase 2, randomised, double-blind trial of acetyl-l-carnitine in peripheral neuropathy, sponsored by Bayer. Started Aug 2008; status: completed.
02
Drugs
acetyl-l-carnitine
03
Conditions
peripheral neuropathy
Beyond the preview
Go deeper on NCT00751205.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00751205.